Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
SinoMab Bioscience Ltd. ( (HK:3681) ) has issued an update.
SinoMab BioScience Limited announced a change in its company secretary position, with Ms. Chow Yuk Yin Ivy resigning and Ms. Lai Florence Wai Ki being appointed as her replacement, effective October 8, 2025. This transition is expected to strengthen the company’s corporate compliance and advisory capabilities, given Ms. Lai’s extensive experience and professional background.
The most recent analyst rating on (HK:3681) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on SinoMab Bioscience Ltd. stock, see the HK:3681 Stock Forecast page.
More about SinoMab Bioscience Ltd.
SinoMab BioScience Limited is a company incorporated in Hong Kong, operating within the biotechnology industry. The company focuses on the development of therapeutic products, particularly in the field of immunology.
Average Trading Volume: 19,863,366
Technical Sentiment Signal: Hold
Current Market Cap: HK$2.53B
See more insights into 3681 stock on TipRanks’ Stock Analysis page.